As of January 9, BioDAO launches Long COVID Labs (COVID).
BIO Protocol is the 63rd project in the Binance Launchpool and It was on the 3rd day of the year when Binance enabled BIO listing.
According to the information issued by BIO Protocol in a new post with regard to X, which it regards as Twitter, The Labs increases on January 9 and seeks to propel a remedy utilizing DeSci technology.
The tick of the project will be COV and collaborators funs include current and ex-Stanford researchers. 1% of the total token supply for the project will be allocated to BIO holders who participate in the auction.
Vision Of Long COVID Labs
According to the project summary that they shared via X, they envisioned the following details, they said that even if Covid 19 is no more in the media, it remains in the people physically- they elaborated that about 20% of the patients that have fully recovered still have viral remnant Spike protein substances in the blood circulation for quite some time.
Furthermore, they also indicated the percentage of patients eligible to be diagnosed with long Covid which is 40 percent are struggling with chronic diseases.
It is reported that a long Covid Labs company was formed to address these issues and possess a bigger vision.
Treat Long Covid
Develop treatments for people around the globe who be reaching billions
Change The Future of medicine.
The founders of the project include the following specialists:
Rohan Dixit - A serial entrepreneur in the health industry, Rohan was a researcher in neuroscience for Standford and MGH Martinos Center, and is a patient of long covid.
Ruth Ann Crystal (MD) - An entrepreneur in medicine at Stanford, who is also a major subscriber to Covid-19 newsletters.
Jacob Glenville - Founder of Centivax, Computational Immunoengineer.
Annelise Barron - A professor of bioengineering at Stanford who develops new medicines.
Largest Decentralized Clinical Trial Network
In the X thread, it follows that the project is the largest decentralized trial network ever built, with the use of machine learning that:
Recognizes trends
Improves the trials
Recommends treatments tailored to the individual
The project also pointed out that while for decades the medicine was ruled by Big Pharma, that benefited from long and costly processes of prioitying investors than the patients, the long covid labs will change this paradigm and have focus on the patients.
Getting Involved
The project uses a DAO model where users/patients have holding governance tokens (COVID) which has the voting power on the proposals made, recommended funding of research, and supervision of the funds obtained.
There are two methods in which you can obtain COVID tokens:
Giving through the research
Stakeholders buy COVID tokens directly to fund the research
The BIO Protocol was launched at the last month of 2024 as the 63rd project of Binance Launchpool.
